General Information of the m6A Target Gene (ID: M6ATAR00655)
Target Name Protein salvador homolog 1 (SAV1)
Synonyms
45 kDa WW domain protein; hWW45
    Click to Show/Hide
Gene Name SAV1
Chromosomal Location 14q22.1
Function
Regulator of STK3/MST2 and STK4/MST1 in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. SAV1 is required for STK3/MST2 and STK4/MST1 activation and promotes cell-cycle exit and terminal differentiation in developing epithelial tissues. Plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with STK3/MST2, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation.
    Click to Show/Hide
Gene ID 60485
Uniprot ID
SAV1_HUMAN
HGNC ID
HGNC:17795
Ensembl Gene ID
ENSG00000151748
KEGG ID
hsa:60485
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
SAV1 can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by ALKBH5
Cell Line 143B cell line Homo sapiens
Treatment: siALKBH5 transfected 143B cells
Control: siControl 143B cells
GSE154528
Regulation
logFC: -1.29E+00
p-value: 1.15E-10
More Results Click to View More RNA-seq Results
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary Inhibiting ALKBH5 in Multiple Myeloma cells increased Protein salvador homolog 1 (SAV1) m6A levels, decreased SAV1 mRNA stability and expression, suppressed the stem cell related HIPPO-pathway signalling and ultimately activates the downstream effector YAP, exerting an anti-myeloma effect.
Target Regulation Up regulation
Responsed Disease Multiple myeloma ICD-11: 2A83.1
Pathway Response Hippo signaling pathway hsa04390
Cell Process Cell proliferation
Cell invasion
In-vitro Model U266 (Human multiple myeloma cells)
RPMI-8226 Plasma cell myeloma Homo sapiens CVCL_0014
NCI-H929 Plasma cell myeloma Homo sapiens CVCL_1600
ARH-77 Human leukemia tumor Homo sapiens CVCL_1072
Multiple myeloma [ICD-11: 2A83]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary Inhibiting ALKBH5 in Multiple Myeloma cells increased Protein salvador homolog 1 (SAV1) m6A levels, decreased SAV1 mRNA stability and expression, suppressed the stem cell related HIPPO-pathway signalling and ultimately activates the downstream effector YAP, exerting an anti-myeloma effect.
Responsed Disease Multiple myeloma [ICD-11: 2A83.1]
Target Regulator RNA demethylase ALKBH5 (ALKBH5) ERASER
Target Regulation Up regulation
Pathway Response Hippo signaling pathway hsa04390
Cell Process Cell proliferation
Cell invasion
In-vitro Model U266 (Human multiple myeloma cells)
RPMI-8226 Plasma cell myeloma Homo sapiens CVCL_0014
NCI-H929 Plasma cell myeloma Homo sapiens CVCL_1600
ARH-77 Human leukemia tumor Homo sapiens CVCL_1072
References
Ref 1 ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m(6)A-demethylation of SAV1 mRNA and Myeloma Stem Cell Phenotype. Int J Biol Sci. 2022 Mar 6;18(6):2235-2248. doi: 10.7150/ijbs.64943. eCollection 2022.